01 4McCarthy Tetrault LLP
01 22936079
02 22990020
01 4REPOTRECTINIB
01 4CAPSULE
01 21935-01-23
02 21936-07-05
Patent Expiration Date : 1936-07-05
Date Granted : 2024-02-27
Brand Name : AUGTYRO
Patent Number : 2990020
Filing Date : 2016-07-05
Strength per Unit : 40 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1936-07-05
Date Granted : 2024-02-27
Patent Expiration Date : 1936-07-05
Date Granted : 2024-02-27
Brand Name : AUGTYRO
Patent Number : 2990020
Filing Date : 2016-07-05
Strength per Unit : 160 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1936-07-05
Date Granted : 2024-02-27
Patent Expiration Date : 1935-01-23
Date Granted : 2022-07-19
Brand Name : AUGTYRO
Patent Number : 2936079
Filing Date : 2015-01-23
Strength per Unit : 40 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1935-01-23
Date Granted : 2022-07-19
Patent Expiration Date : 1935-01-23
Date Granted : 2022-07-19
Brand Name : AUGTYRO
Patent Number : 2936079
Filing Date : 2015-01-23
Strength per Unit : 160 mg
Dosage Form : CAPSULE
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1935-01-23
Date Granted : 2022-07-19
